Covered recipient · General Payments record
DALTON DIEGEL
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2025
$1,364.19
- Reported across 55 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,264.20 | 54 |
| Education | $99.99 | 1 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Genentech USA, Inc. | $171.67 | 11 |
| Incyte Corporation | $152.67 | 4 |
| PharmaEssentia USA Corporation | $132.25 | 2 |
| Amgen Inc. | $107.83 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $74.65 | 3 |
| Daiichi Sankyo Inc. | $59.04 | 3 |
| Caris MPI, Inc. | $53.59 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $51.31 | 2 |
| SOBI, INC | $41.76 | 2 |
| GENZYME CORPORATION | $41.72 | 1 |
| Merck Sharp & Dohme Corporation | $41.10 | 2 |
| TerSera Therapeutics LLC | $40.81 | 2 |
| Deciphera Pharmaceuticals Inc. | $34.88 | 2 |
| Janssen Biotech, Inc. | $34.35 | 2 |
| E.R. Squibb & Sons, L.L.C. | $31.79 | 1 |
| Regeneron Healthcare Solutions, Inc. | $29.71 | 1 |
| BeOne Medicines USA, Inc. | $27.81 | 1 |
| Acerta Pharma LLC | $26.81 | 1 |
| Rigel Pharmaceuticals, Inc. | $23.30 | 1 |
| EMD Serono, Inc. | $23.04 | 1 |
| Fresenius Kabi USA, LLC | $22.26 | 1 |
| EISAI INC. | $20.95 | 1 |
| Karyopharm Therapeutics Inc. | $20.33 | 1 |
| Celgene Corporation | $19.41 | 1 |
| SERVIER PHARMACEUTICALS LLC | $18.75 | 1 |
| Astellas Pharma US Inc | $16.85 | 1 |
| AVEO Pharmaceuticals, Inc. | $15.91 | 1 |
| Azurity Pharmaceuticals, Inc. | $15.01 | 1 |
| Geron Corporation | $14.63 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2025 | $1,364.19 | 55 |
Payment records · PY2025 (55)
Ordering applied by this site (paying entity, then date) · record values are shown as CMS published them
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2025
- Source files
- Dataset page · Bulk file · PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.